HYPEROXALURIA: FORMATION MECHANISMS AND CONSEQUENCES
Abstract
The work is a literature review, which demonstrates the current view on the mechanisms underlying the formation of hyperoxaluria and possible outcomes. The article includes detailed information on the biochemistry of oxalate, exogenous and endogenous resources in the human body, mechanisms of oxalate absorption in the gastrointestinal tract and renal excretion. Thefinal sectionfocuses on existing andpromising approaches to the treatment ofhyperoxaluria.
Downloads
References
Колесник М. Гіпероксалурія та показники мукозального імунітету хворих на хронічну хворобу нирок І-ІІ ст.: пієлонефрит / М. Колесник, Н. Сташевська, Н. Степанова, В. Дріянська, та інші // Український Журнал Нефрології та Діалізу. - 2014. -№3 (43). - С. 42-48.
Колесник М. Гіпероксалурія у хворих на пієлонефрит: потенційна роль у прогресуванні хронічної хвороби нирок / М. Колесник, Н. Степанова, Н. Сташевська, Л. Суржко // Український журнал нефрології та діалізу. – 2012. -№2(34).-С. 28-33.
Aaron W. Miller. The Metabolic and Ecological Interactions of Oxalate-Degrading Bacteria in the Mammalian Gut. / Aaron W. Miller, Denise Dearing // Pathogens – 2013. –V. 2. – P. 636-652.
Abeysekera R. A. Star fruit toxicity: a cause of both acute kidney injury and chronic kidney disease: a report of two cases (Electronic resource) / Abeysekera R. A., Wijetunge S., Nanayakkara N., [et al.] // BMC Research Notes. – 2015. – V. 8. – Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683968/
Agrawal V. Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass / AgrawalV., LiuX. J., CampfieldT., [etal.] // Surg Obes Relat Dis. - 2013.-V. 10. - P. 88-94.
Albersmeyer M. Acute kidney injury after ingestion of rhubarb: secondary oxalate nephropathy in a patient with type 1 diabetes (Electronic resource) / Albersmeyer M., Hilge R., Schrttle A., Weiss
M., Sitter T., Vielhauer V. // BMC Nephrology. – 2012. –V. 13. – Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504561
Al-Wahsh I. Acute probiotic ingestion reduces gastrointestinal oxalate absorption in healthy subjects / Al-Wahsh I., Wu Y., Liebman M. // Urol. Res. - 2012. - V. 40 (3). - P. 191-196.
An institutional experience of pre-emptive liver transplantation for pediatric primary hyperoxaluria type 1 / Khorsandi S. E., Samyn M., Hassan A., Vilca-Melendez H., [et al.] // Pediatr Transplant. 2016. – V. 20(4).-P. 523-529.
Antonelli J. A. Defining variation in urinary oxalate in hyperoxaluric stone-formers / Antonelli J. A., Langman С. B., Odom C., Poindexter J., [et al.] // J Endourol. - 2013. - V. 27 (12). - P. 1530-1534.
Bakul G. Acute oxalate nephropathy due to ‘Averrhoa bilimbi’ fruit juice ingestion / Bakul G., Unni V. N., Seethaleksmy N. V., Mathew A., Rajesh R., [et al.] // Indian J Nephrol. – 2013. – V. 23. - P. 297-300.
Barnett C. The presence of Oxalobacter formigenes in the microbiome of healthy young adults Barnett C., Nazzal L., Goldfarb D. S., Blaser M. J. // The Journal of urology. - 2016. - V. 195 (2). - P. 499-506.
Barr-Beare E. The Interaction between Enterobacteriaceae and Calcium Oxalate Deposits (Electronic resource) / Barr-Beare E., Saxena V., Hilt E. E., [et al.] // Sands JM, ed. PLoS ONE. - 2015. – V. 10 (10). – Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598009
Bhasin B. Primary and secondary hyperoxaluria: Understanding the enigma / Bhasin B., Urekli H. M., Atta M. G. //World Journal of Nephrology. – 2015. –V. – 4 (2). - P. 235-244.
Canales В. K. Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate / Canales В. K., Ellen J., Khan S. R., [et al.] // J Urol. - 2013. - V. 190. - P. 1102-1109.
Cartery C. Oxalate Nephropathy Associated with Chronic Pancreatitis / Cartery C., Faguer S., Karras A., [et al.] II Clinical Journal of the American Society of Nephrology: CJASN. – 2011. – V. 6 (8). – P. 1895-1902.
Chen P. Correlation between urinary stones and urinary tract infections / Chen P., Zhang L., Meng B. // Zhonghua Liu Xing Bing Xue Za Zhi. – 2014. -V.35(5).-P. 597-599.
Cochat Р. Primary hyperoxaluria / Cochat P., Rumsby G. // N Engl J Med. - 2013. - V. 369. - P. 649-658.
Cohen-Bucay A. Acute oxalate nephropathy associated with Clostridium difficile colitis / Cohen- Bucay A., Garimella P., Ezeokonkwo C., Bijol V., Strom J. A., Jaber B. L. // Am J Kidney Dis. - 2014. – V. 63(1).-P. 113-118.
Combined kidney and intestinal transplantation in patients with enteric hyperoxaluria secondary to short bowel syndrome / Ceulemans L. J., Nijs Y., Nuytens F., De Hertogh G., Claes K., [et al.]. // Am J Transplant.-2013.-V. 13.-P. 1910-1914.
Cossey L. N. Oxalate nephropathy and intravenous vitamin C / Cossey L. N., Rahim F., Larsen С. P. // Am J Kidney Dis. - 2013. -V. 61. - P. 1032-1035.
Di Cerbo A. Mechanisms and therapeutic effectiveness of lactobacilli / Di Cerbo A., Palmieri B., Aponte M., [et al.] // Journal of Clinical Pathology - 2016. -V. 69 (3). - P. 187-203.
Dutta C. Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1 / Dutta C., Avitahl-Curtis N., Pursell N., [et al.] // Molecular Therapy. – 2016. – V. 24 (4).-P. 770-778.
Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn’s disease / Hueppelshaeuser R., von Unruh G. E., Habbig S., Beck В. B., [et al.] // Pediatr Nephrol. – 2012. – V. 27(7).-P. 1103-1109.
ERRATUM: Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group / Prezioso D., Strazzullo P., Lotti T., Bianchi G., Borghi L., Caione P., Carini M., [et al.] // Arch Ital Urol Androl. – 2016. – V. 31, 88(l).-76p.
Ferraro P. M. Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones / Ferraro P. M., Curhan G. C., Gambaro G., Taylor E. N. // Kidney Dis. - 2016. - V. 67 (3). - P. 400-407.
Freel R. W. Transcellular oxalate and Cl- absorption in mouse intestine is mediated by the DRA anion exchanger Slc26a3, and DRA deletion decreases urinary oxalate / Freel R. W., Whittamore J. M., Hatch M. // American Journal of Physiology - Gastrointestinal and Liver Physiology. – 2013. – V. 305 (7). - P. 520-527.
Gonzalez R. D. Kidney Stone Risk Following Modern Bariatric Surgery / Gonzalez R. D., Canales В. K. // Current urology reports. – 2014. -V. 15(5).-P. 401.
Grases F. New aspects on the composition, structure and origin of calcium oxalate monohydrate calculi / Grases F., March J. G., Conte A., Costa- Bauza A. // Eur Urol. - 1993. - V. - 24 (3). - P. 381-386.
Guidelines on Urolithiasis / C. T rk, T. Knoll, A. Petrik [et al.] // European Association of Urology. – 2013.
Gurm H. Vitamin C-induced oxalate nephropathy: a case report / Gurm H., Sheta M. A., Nivera N., Tunkel A. // J Community Hosp Intern Med Perspect. - 2012. – V. 2. - P. 17718.
Harambat J. Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy / Harambat J., van Stralen K. J., Espinosa L., Groothoff J. W., Hulton S. A., [et al.] // European Society for Pediatric Nephrology/ European Renal Association-European Dialysis and Transplant Association (ESPN/ERA-EDTA) Registry Clin J Am Soc Nephrol. – 2012. – V. 7 (3).-P. 458-465.
Hassan I. Chronic renal failure secondary to oxalate nephropathy: a preventable complication after jejunoileal bypass / Hassan I. , Juncos L. A., Milliner D. S., Sarmiento J. M., [et al.] // Clin Proc. - 2001. - V. 76. - P. 758-760.
Hatch M. Intestinal transport of an obdurate anion: oxalate / Hatch M., Freel R. W. // Urol. Res. – 2005. – V. 33(1).-P. 1-16.
Hatch M. The Roles and Mechanisms of Intestinal Oxalate Transport in Oxalate Homeostasis / Hatch M., Freel R. W. // Seminars in nephrology. – 2008. -V.28(2).-P. 143-151.
HerlitzL. C. Crystalline nephropathies / Herlitz L. C. , D’AgatiV. D., Markowitz G. S.// Arch Pathol Lab Med. – 2012. – V. 136.-P. 713-720.
Holmes R. P. Contribution of dietary oxalate to urinary oxalate excretion / Holmes R. P., Goodman H. O., Assimos D. G. // Kidney Int. – 2001. – V.59(l).-P. 270-276.
Holmes R. P. Impact of dietary oxalate on kidney stone formation / Holmes R. P., Assimos D. G.// Urol Res. - 2004. - V. 32 (5). - P. 311-316.
Holmes R. P. The Hatch M. A Human Strain of Oxalobacter (HC-1) Promotes Enteric Oxalate Secretion in the Small Intestine of Mice and Reduces Urinary Oxalate Excretion (Electronic resource) / Hatch M., Freel R. W. // Urolithiasis. – 2013. – V. 41 (5). – Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815490/
Hoppe B. An update on primary hyperoxaluria / Hoppe B. // Nat Rev Nephrol. – 2012. – V. 8. – P. 467-475.
Hoyer-Kuhn H. Vitamin B6 in Primary Hyperoxaluria I: First Prospective Trial after 40 Years of Practice. Clin J Am Soc Nephrol / Heike Hoyer-Kuhn, Sina Kohbrok, RuthVolland, [et al.] // 2014. –V.7,9 (3). - P. 468-477.
Humayun Y. Acute oxalate nephropathy associated with orlistat / Humayun Y., Ball K. C., Lewin J. R., Lerant A. A., Fulop T. // Journal of Nephropathology. – 2016. –V.5 (2). – P. 79-83.
Hyperoxaluria: a gut-kidney axis? / Robijn S., Hoppe B., Vervaet B. A., D’Haese P. C., Verhulst A. //Kidney Int. - 2011. -V. - 80. P. 1146-1158.
lilies F. Clearance and removal of oxalate in children on intensified dia//lysis for primary hyperoxaluria type / lilies F., Bonzel К. E., Wingen A. M. , Latta К., Hoyer P. F.// Kidney Int. – 2006. – V. 70. - P. 1642-1648.
Jakobsson H. E. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome (Electronic resource) / Jakobsson H. E., Jernberg C., Andersson A. F., Sj lund-Karlsson M., [et al.] // PLoS One. 2010. — Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844414
Jandhyala S. M. Role of the normal gut microbiota / Jandhyala S. M., Talukdar R., Subramanyam C., Vuyyuru H., [et al] // World Journal of Gastroenterology: WJG. - 2015. - V. 21 (29). - P. 8787-8803.
Jernberg C. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota / Jernberg C., Lofmark S., Edlund C., Jansson J. К. //ISME J. - 2007. - V. 1. - P. 56-66.
Jiang J. Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion / J. Jiang, J. Knight, L. H. Easter, R. Neiberg [et al.] // J Urol. - 2011. - Vol. 186 (l).-P. 135-139.
Kaufman David W. Oxalobacter formigenes May Reduce the Risk of Calcium Oxalate Kidney Stones / David W. Kaufman, Judith P. Kelly, Gary C. Curhan, Theresa E. Anderson [et al.] // J Am Soc Nephrol.-2008.-Vol. 19 (6). - P. 1197-1203.
Khan S. R. Crystal-induced inflammation of the kidneys: Results from human studies, animal models, and tissue-culture studies / Khan S. R. // Clin Exp Nephrol. - 2004. -№8,- P. 75-88.
Knauf F. Net Intestinal Transport of Oxalate Reflects Passive Absorption and SLC26A6- mediated Secretion / Knauf F., Ко N., Jiang Z., [et al] II Journal of the American Society of Nephrology. - 2011. – V. 22 (12). - P. 2247-2255.
Knight J. Ascorbic acid intake and oxalate synthesis (Electronic resource) / Knight J., Madduma- Liyanage K., Mobley J. A., [et al.] // Urolithiasis. – 2016. – Mode of access: http://www.ncbi.nlm.nih.gov/pubmed/27002809
Knight J. Hydroxyproline ingestion and urinary oxalate and glycolate excretion / Knight J., JiangJ ., Assimos D., Holmes R. // Kidney international. – 2006. – V. 70 (11). – P. 1929-1934.
Kolesnyk M. Effect of hyperoxaluria on the progression of chronic kidney disease in women with recurrent uncomplicated pyelonephritis / M. Kolesnyk, N. Stepanova, L. Surzhko, N. Stashevska //
Nephrology Dialysis Transplantation. – 2012. – Vol. 27 (Suppl 2). - P. 107.
Kolesnyk M. Hyperoxaluria associated with recurrent pyelonephritis in women (Electronic resource) / Kolesnyk M., Stepanova N., Stashevska N. // World Congress ofNephrology. – 2013. – Mode of access: http://www.abstracts2view.com/wcn/view.php?nu=WCN13L_1615
Kolesnyk M. Hyperoxaluria mediated renal injury in women with recurrent pyelonephritis / Kolesnyk M., Stepanova N., Driyanska V., Stashevska N., Kundin V. //Nephrology Dialysis Transplantation. -2013.-V. 26 (Suppl.). – P. 114.
Krick W. Ability of sat-1 to transport sulfate, bicarbonate, or oxalate under physiological conditions / Krick W., Schnedler N., Burckhardt G. [et al.] // Am J Physiol Renal Physiol. – 2009. – V. 297. – P.145-154.
Kumar R. Fat malabsorption and increased intestinal oxalate absorption are common after Roux- en-Y gastric bypass surgery / Kumar R., Lieske J. C., Collazo-Clavell M. L., [et al.] // Surgery. – 2011. – V. 149. - P. 654-661.
Kynast-Gales S. A. Food oxalate: an international database / Kynast-Gales S. A., Massey L. K. // J Am Diet Assoc. – 2007. –V. 107. – P. 1099.
Famarche J. Vitamin C-induced oxalate nephropathy (Electronic resource) / Lamarche J., Nair R., Peguero A., Courville C. // Int J Nephrol. – 2011. – Mode of access: http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3096888/
Lange J. N. Sensitivity of Human Strains of Oxalobacter formigenes to Commonly Prescribed Antibiotics / Lange J. N., Wood K. D., Wong H., [et al.] Ц Urology. - 2012. - V. 79 (6). - P. 1286-1289.
Leal C. Herlitz. Crystalline Nephropathies / Leal C. Herlitz, Vivette D. D’Agati, Glen S. Markowitz // Archives of Pathology & Laboratory Medicine. – 2012. – V. - 136 (7). - P. 713-720.
Liebman M. Probiotics and Other Key Determinants of Dietary Oxalate Absorption / Michael Liebman, Ismail A. Al-Wahsh // Adv. Nutr. – 2011. – V. 2 (3). - P. 254-260.
Lieske J. C. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation / Lieske J. C., Tremaine W. J., De Simone C., O’Connor H. M., [et al.] //Kidney Int. – 2010. – V. 78. – P. 1178-1185.
Massey L. К Food oxalate: factors affecting measurement, biologicalvariation, andbioavailability / Massey L. K. // J Am Diet Assoc. – 2007. – V. – 107(7). – P. 1191-1194.
Mogna L. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? / Mogna L., Pane M., Nicola S., Raiteri E. // J Clin Gastroenterol. – 2014. – V. 48, Suppl 1. - P. 91-95.
Monico C. G. Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic, calcium oxalate urolithiasis / Monico C. G., Rossetti S., Belostotsky R., [et al.] // Clin J Am Soc Nephrol. - 2011. - V. 6. - P. 2289-2295.
Nazzal L. Enteric hyperoxaluria: an important cause of end-stage kidney disease / Nazzal L., Puri S., Goldfarb D. // Nephrol. Dial. Transplant. – 2016. – V. 31 (3).-P. 375-382.
Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease / Glew R. H., Sun Y., Horowitz B. L., et al. // World Journal of Nephrology. –2014. –V. 3 (4). – P. 122-142.
Panda S. Short-term effect of antibiotics on human gut microbiota (Electronic resource) / Panda S., Elkhader I., Casellas F., Lopez Vivancos J., [et al.] // PLoS One. - 2014. - V. 9 (4). - Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991704
Peanut-induced acute oxalate nephropathy with acute kidney injury / Park H., Eom M., Won Yang J., Geun Han B., [et al.] //Kidney Research and Clinical Practice. - 2014. - V. 33 (2). - P. 109
Ritz E. Bariatric surgery and the kidney-much benefit, but also potential harm / Ritz E. // Clinical Kidney Journal. - 2013.-V. 6 (4). - P. 368-372.
Salido E. Primary hyperoxalurias: disorders of glyoxylate detoxification / Salido E., Pey A. L., Rodriguez R., Lorenzo V. // Biochim Biophys Acta. - 2012. - V. 1822 (9). - P. 1453-1464.
Sasikumar P. Secretion of Biologically Active Heterologous Oxalate Decarboxylase (OxdC) in Lactobacillus plantarum WCFS1 Using Homologous Signal Peptides (Electronic resource) / Sasikumar P., Gomathi S., Anbazhagan K., Selvam G. S. //BioMed Research International. – 2013. – Mode of access: http://www.ncbi.nlm.nih. gov/pmc/articles/PMC3732618/doi:10.1155/201
Siener R. Determinants of urolithiasis in patients with intestinal fat malabsorption / Siener R., Petzold J., Bitterlich N., Alteheld B., Metzner C. // Urology. - 2013. – V. 81. – P. 17-24.
Siener R. Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria / Siener R., Bade D.J., Hesse A., Hoppe B.// J Transl Med. – 2013. – V. ll.-P. 306.
Sorensen M. D. Impact of Nutritional Factors on Incident Kidney Stone Formation: A Report From the WHI OS / Sorensen M. D., Kahn A. J., Reiner A. P., et al. II The Journal of urology. – 2012. – V. 187(5).-P. 1645-1649.
Stackhouse G. B. Calcium Physiology. / Stackhouse G. B., Stoller M. L. IIUrinary Stone Disease. – 2007. – Humana Press Inc. – P. 85–101.
Stepanova N. Hyperoxaluria in women with recurrent pyelonephritis associated with the deficit of Lactobacillus spp. in the gut and vaginal microbiota / Stepanova N., Kolesnyk M., Stashevska N. // European urology supplements. – 2015. – P. 50-51.
Stieger B. Regulation of the expression of the hepatocellular sulfate-oxalate exchanger SAT-1 (SLC26A1) by glyoxylate: a metabolic link between liver and kidney? / Stieger B. // J Hepatol. – 2011. -V. 54. – P. 406-407.
Susan R. Marengo. Oxalate in Renal Stone Disease: The Terminal Metabolite: Excretion of Oxalate. / Susan R. Marengo, Andrea M. P. //Nat Clin Pract Nephrol. - 2008. –V.4 (7). -P.- 368-377.
Tang X. Acute and chronic kidney injury in nephrolithiasis / Xiaojing Tang, John C. Lieske // Curr Opin Nephrol Hypertens. – 2014. – V. 23 (4). – P. 385-390.
Taylor E. N. DASH-Style Diet Associates with Reduced Risk for Kidney Stones / Taylor E. N., Fung T. T., Curhan G. C. // Journal of the American Society of Nephrology. – 2009. – V. 20 (10). – P. 2253-2259.
Tran M. H. Kidney transplantation in obese patients / Tran M. H., Foster C. E., Kalantar-Zadeh K., Ichii H. // World Journal of Transplantation. – 2016.-V.6(1).-P. 135-143.
Turroni S. Oxalate-degrading activity in Bifidobacterium animalis subsp. lactis: Impact of acidic conditions on the transcriptional levels of the oxa- lyl-CoA decarboxylase and formyl-CoA transferase genes / Turroni, S., Bendazzoli C., Dipalo S. C. F., Candela M., [et al.] // Appl. Environ. Microbiol. – 2010. – V. 76. – P. 5609-5620.
Weight loss at a high cost: Orlistat-induced late-on- set severe kidney disease / Buysschaert B., Aydin S., Morelle J., Hermans M. P., [et al.] // N. Diabetes Metab. - 2016. – V. 42 (1). - P. 62-64.
Whitson J. M. Hyperoxaluria after modern bariatric surgery: case series and literature review //Whitson J. M., Stackhouse G. B., Stoller M. L. // Int Urol Nephrol. - 2010. - V. 42. - P. 369-374.
